Finance Watch: VC Mega-Rounds Surge Again, Led By Acelyrin’s $300m Series C

Clinical-Stage Firms Remain Private In Tough Stock Market

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.